The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539
IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice
Cai, D., Frantz, J. D., Tawa, N. E., Melendez, P. A., Oh, B.-C., Lidov, H. G. W., Hasselgren, P.-O., Frontera, W. R., Lee, J., Glass, D. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.027 · Cited by 1,367
The Molecular Basis of Muscular Dystrophy in the mdx Mouse: a Point Mutation
Sicinski, P., Geng, Y., Ryder-Cook, A. S., Barnard, E. A., Darlison, M. G., & Barnard, P. J. (1989) · Science · doi:10.1126/science.2662404 · Cited by 1,276
Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle
Blake, D. J., Weir, A., Newey, S. E., & Davies, K. E. (2002) · Physiological Reviews · doi:10.1152/physrev.00028.2001 · Cited by 1,242
Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
Ervasti, J. M., Ohlendieck, K., Kahl, S. D., Gaver, M. G., & Campbell, K. P. (1990) · Nature · doi:10.1038/345315a0 · Cited by 1,025
The Molecular Basis of Skeletal Muscle Atrophy
Jackman, R. W., & Kandarian, S. C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00579.2003 · Cited by 1,008 · cited 3×
“Such a pathway could be the proteasome system, since studies have established the requirement of musclespecific E3 ligases, MuRF1 and atrogin-1/MAFBx, in several cachectic states (Jackman and Kandarian, 2004).”
BackgroundTisdale, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc927 · Cited by 982
NF-κB-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia
Guttridge, D. C., Mayo, M. W., Madrid, L. V., Wang, C.-Y., & Baldwin Jr., A. S. (2000) · Science · doi:10.1126/science.289.5488.2363 · Cited by 924
Self-citationAndreyev, H. J. N., Norman, A. R., Oates, J., & Cunningham, D. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10090-9 · Cited by 797
Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophies
Michele, D. E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R. D., Satz, J. S., Dollar, J., Nishino, I., Kelley, R. I., Somer, H., et al. (2002) · Nature · doi:10.1038/nature00837 · Cited by 779 · cited 5×
“agarose beads (Vector Labs) as previously described (Michele et al., 2002).”
BackgroundMethodInfluentialLecker, S. H., Solomon, V., Mitch, W. E., & Goldberg, A. L. (1999) · The Journal of Nutrition · doi:10.1093/jn/129.1.227s · Cited by 732
Signalling pathways that mediate skeletal muscle hypertrophy and atrophy
Glass, D. J. (2003) · Nature Cell Biology · doi:10.1038/ncb0203-87 · Cited by 694
Expression of full-length utrophin prevents muscular dystrophy in mdx mice
Tinsley, J., Deconinck, N., Fisher, R., Kahn, D., Phelps, S., Gillis, J.-M., & Davies, K. (1998) · Nature Medicine · doi:10.1038/4033 · Cited by 615
Badorff, C., Lee, G.-H., Lamphear, B. J., Martone, M. E., Campbell, K. P., Rhoads, R. E., & Knowlton, K. U. (1999) · Nature Medicine · doi:10.1038/6543 · Cited by 575
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products
Acharyya, S., Ladner, K. J., Nelsen, L. L., Damrauer, J., Reiser, P. J., Swoap, S., & Guttridge, D. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420174 · Cited by 542
Self-citationThe Dystrophin Glycoprotein Complex: Signaling Strength and Integrity for the Sarcolemma
Lapidos, K. A., Kakkar, R., & McNally, E. M. (2004) · Circulation Research · doi:10.1161/01.res.0000126574.61061.25 · Cited by 524
Glycoprotein Complex Anchoring Dystrophin to Sarcolemma1
Yoshida, M., & Ozawa, E. (1990) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a123276 · Cited by 503
Animal models for muscular dystrophy show different patterns of sarcolemmal disruption
Straub, V., Rafael, J. A., Chamberlain, J. S., & Campbell, K. P. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.2.375 · Cited by 488
Expression Profiling in the Muscular Dystrophies
Chen, Y.-W., Zhao, P., Borup, R., & Hoffman, E. P. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.6.1321 · Cited by 478
Tumor necrosis factor-α and muscle wasting: a cellular perspective
Reid, M. B., & Li, Y.-P. (2001) · Respiratory Research · doi:10.1186/rr67 · Cited by 457
MOKRI, B., & ENGEL, A. G. (1975) · Neurology · doi:10.1212/wnl.25.12.1111 · Cited by 449
Durbeej, M., & Campbell, K. P. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00309-x · Cited by 435
Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice.
Ohlendieck, K., & Campbell, K. P. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.6.1685 · Cited by 425
Rando, T. A. (2001) · Muscle & Nerve · doi:10.1002/mus.1192 · Cited by 424
Control of the size of the human muscle mass
Rennie, M. J., Wackerhage, H., Spangenburg, E. E., & Booth, F. W. (2004) · Annual Review of Physiology · doi:10.1146/annurev.physiol.66.052102.134444 · Cited by 399
BODENSTEINER, J. B., & ENGEL, A. G. (1978) · Neurology · doi:10.1212/wnl.28.5.439 · Cited by 388
Systemic inflammation, cachexia and prognosis in patients with cancer
Deans, C., & Wigmore, S. J. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000165004.93707.88 · Cited by 331
Kumar, A., & Boriek, A. M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0542com · Cited by 301
Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice
Phelps, S. F., Hauser, M. A., Cole, N. M., Rafael, J. A., Hinkle, R. T., Faulkner, J. A., & Chamberlain, J. S. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.8.1251 · Cited by 288
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-6-879_2 · Cited by 281
Muscle Cachexia: Current Concepts of Intracellular Mechanisms and Molecular Regulation
Hasselgren, P.-O., & Fischer, J. E. (2001) · Annals of Surgery · doi:10.1097/00000658-200101000-00003 · Cited by 277
Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy
Hunter, R. B., & Kandarian, S. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421696 · Cited by 250
The role of cytokines in cancer cachexia
Argilés, J. M. A., & López-Soriano, F. J. (1999) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199905)19:3<223::aid-med3>3.0.co;2-n · Cited by 234
Muscular dystrophies: genes to pathogenesis
Dalkilic, I., & Kunkel, L. M. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00048-0 · Cited by 220
Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats.
Temparis, S., Asensi, M., Taillandier, D., AUROUSSEAU, E., Larbaud, D., Obled, A., Béchet, D., Ferrara, M., Estrela, J. M., & Attaix, D. (1994) · PubMed · Cited by 214
Williams, A., Sun, X., Fischer, J. E., & Hasselgren, P.-O. (1999) · Surgery · doi:10.1016/s0039-6060(99)70131-5 · Cited by 196
Biosynthesis of dystroglycan: processing of a precursor propeptide
Holt, K. H., Crosbie, R. H., Venzke, D. P., & Campbell, K. P. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01195-9 · Cited by 177
Cox, G. A., Sunada, Y., Campbell, K. P., & Chamberlain, J. S. (1994) · Nature Genetics · doi:10.1038/ng1294-333 · Cited by 171
Molecular Mechanisms of Muscle Atrophy
McKinnell, I. W., & Rudnicki, M. A. (2004) · Cell · doi:10.1016/j.cell.2004.12.007 · Cited by 162
Seidman, R. (2001) · Journal of Clinical Neuromuscular Disease · doi:10.1097/00131402-200112000-00014 · Cited by 152
Cancer cachexia: the molecular mechanisms
Argilés, J. M. A., Moore‐Carrasco, R., Fuster, G., Busquets, S., & López-Soriano, F. J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00251-0 · Cited by 132
Xia, B., Hoyte, K., Kammesheidt, A., Deerinck, T. J., Ellisman, M. H., & Martin, P. T. (2002) · Developmental Biology · doi:10.1006/dbio.2001.0530 · Cited by 80
Farges, M., Balcerzak, D., Fisher, B. D., Attaix, D., Béchet, D., Ferrara, M., & Baracos, V. E. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00345.2001 · Cited by 79
The fine structure of type II muscle fiber atrophy
Mendell, J. R., & Engel, W. K. (1971) · Neurology · doi:10.1212/wnl.21.4.358 · Cited by 64
The effects of post‐translational processing on dystroglycan synthesis and trafficking1
Esapa, C. T., Bentham, G. R. B., Schröder, J. E., Kröger, S., & Blake, D. J. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01230-4 · Cited by 52
Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas
Jing, J., Lien, C. F., Sharma, S., Rice, J., Brennan, P. A., & Górecki, D. C. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.05.018 · Cited by 48
Liu, Z., Wu, Y., Nicklas, E. W., Jahn, L. A., Price, W. J., & Barrett, E. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00146.2003 · Cited by 41
Hertlein, E. K., Wang, J., Ladner, K. J., Bakkar, N., & Guttridge, D. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.4956-4968.2005 · Cited by 34
Self-citationChanges in skeletal muscle associated with cachexia.
Marin, O. S. M., & Denny-Brown, D. E. (1962) · PubMed Central · Cited by 27
Cited by
Baracos, V. E., Martin, L., Korc, M., Guttridge, D. C., & Fearon, K. C. H. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.105 · Cited by 1,738
Self-citationCancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Fearon, K. C. H., Glass, D. J., & Guttridge, D. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.011 · Cited by 1,205
Self-citationTisdale, M. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00016.2008 · Cited by 1,192
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., Rosenfeld, R., Chen, Q., Boone, T., Simonet, W. S., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.011 · Cited by 940
Signaling in Muscle Atrophy and Hypertrophy
Sandri, M. (2008) · Physiology · doi:10.1152/physiol.00041.2007 · Cited by 827
Metadata
- Authors
- Acharyya, S., Butchbach, M. E. R., Sahenk, Z., Wang, H., Saji, M., Carathers, M., Ringel, M. D., Skipworth, R. J. E., Fearon, K. C. H., Hollingsworth, M. A., Muscarella, P., Burghes, A. H. M., Rafael-Fortney, J. A., & Guttridge, D. C.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2005-11
- Volume
- 8
- Issue
- 5
- Pages
- 421-432
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2153387767
- Cited by
- 314
- References
- 54
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.